Trial Profile
Study to Evaluate the Efficacy, Safety of Infliximab in Patients With Refractory Intestinal Behcet's Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jun 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Behcet's syndrome
- Focus Therapeutic Use
- 19 Jun 2015 New trial record